None
Quote | Evotec SE (NYSE:EVO)
Last: | $ |
---|---|
Change Percent: | 0.08% |
Open: | $12.61 |
Close: | $12.62 |
High: | $12.62 |
Low: | $12.55 |
Volume: | 19,443 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Evotec SE (NYSE:EVO)
2024-04-18 08:25:02 ET More on Evotec SE Business Update Call Seeking Alpha’s Quant Rating on Evotec SE Historical earnings data for Evotec SE Financial information for Evotec SE Read the full article on Seeking Alpha For further detail...
COLLABORATION LEVERAGES VARIANT BIO'S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC'S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC INDICATIONS COMMERCIAL TERMS INCLUDE RESEARCH FUNDING AND MILESTONES AND/OR ROYALTY PAYMENTS ...
Message Board Posts | Evotec SE (NYSE:EVO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $EVTCY News Article - Evotec Launches 'BeLAB2122', Translating Academic Innovation from | whytestocks | investorshangout | 04/13/2021 3:40:53 PM |
whytestocks: $EVTCY News Article - Evotec, Sensyne Health, The University Of Oxford, OSI, and OUI Cr | whytestocks | investorshangout | 06/24/2019 1:35:40 PM |
Emylers: EVTCY Financials Monday, July 14, 2014 10:38:01 PM Evotec AG EVTCY is either non-reporting | Emylers | investorshangout | 07/15/2014 2:38:03 AM |
Stock_Tracker: Latest Evotec Ag Ads (EVTCY) Headlines Will Johnson & Johnson's New Alzheimer's Partn | Stock_Tracker | investorshangout | 03/09/2014 11:23:23 PM |
chartguy89: EVTCY 11.18 Stock Charts $EVTCY 1 Month Chart | chartguy89 | investorshangout | 03/07/2014 9:01:57 AM |
News, Short Squeeze, Breakout and More Instantly...
Evotec SE Company Name:
EVO Stock Symbol:
NYSE Market:
COLLABORATION LEVERAGES VARIANT BIO'S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC'S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC INDICATIONS COMMERCIAL TERMS INCLUDE RESEARCH FUNDING AND MILESTONES AND/OR ROYALTY PAYMENTS ...
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS PR Newswire COLLABORATION LEVERAGES VARIANT BIO'S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC'S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADD...
HAMBURG, GERMANY / ACCESSWIRE / April 17, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce its financial results for 2023 on Wednesday, 24 April 2024. The Company is going to hold a conference call to discuss the results as well as prov...